Clinical Trial Update: Hepatitis C Pharmacy-based Strategy for Injectors

View source ↗

Summary

A completed clinical trial (NCT04698629) evaluating a pharmacy-based strategy for delivering Hepatitis C treatment. Results were posted on 2024-06-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Washington | Conditions: Hepatitis C | Status: COMPLETED | Results posted: 2024-06-07